| NCT06471673 | A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer | RECRUITING | PHASE1, PHASE2 | 2024-05-29 | 2025-10-30 | 2025-04-30 |
| NCT06072612 | Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. | RECRUITING | PHASE3 | 2023-12-05 | 2026-06 | 2026-01 |
| NCT03328026 | Combination Study of SV-BR-1-GM With Retifanlimab | ENROLLING_BY_INVITATION | PHASE1, PHASE2 | 2018-03-16 | 2028-11-30 | 2025-11-03 |
| NCT03066947 | SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer | COMPLETED | PHASE1, PHASE2 | 2017-05-05 | 2018-11-22 | 2018-11-22 |